KODIAK SCIENCES SHARES UP 32% PREMARKET AFTER ZENKUDA AND TABIRAFUSP-TED MEET PRIMARY ENDPOINTS IN DAYBREAK TRIAL IN WET AGE-RELATED MACULAR DEGENERATION

Reuters · 2d ago

Please log in to view news